Return to homepagePandemic Pact

Discovery and development of new antivirals for the control and treatment of SARS-CoV-2 (COVID-19) infection]

Grant number: unknown

Grant search

Key facts

  • Disease

    COVID-19

  • Known Financial Commitments (USD)

    $243,756

  • Funder

    Other funders (France)

  • Principal Investigator

    Thomas BAUMERT

  • Research Location

    France

  • Lead Research Institution

    Directeur de Institut de recherche sur les maladies virales et hépatiques, Strasbourg

  • Research Priority Alignment

    N/A

  • Research Category

    Pathogen: natural history, transmission and diagnostics

  • Research Subcategory

    Pathogen morphology, shedding & natural history

  • Special Interest Tags

    N/A

  • Study Type

    Non-Clinical

  • Clinical Trial Details

    N/A

  • Broad Policy Alignment

    Pending

  • Age Group

    Not Applicable

  • Vulnerable Population

    Not applicable

  • Occupations of Interest

    Not applicable

Abstract

The TargEnt-Covid-19 project aims to identify cellular factors that allow the Sars-CoV-2 virus to enter its host cells. It will also involve highlighting one or more compounds capable of blocking this action and which could constitute future therapeutic molecules.